MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited, has received Helsinki and Ministry of Health approvals for the conducting of its Phase 2 clinical study into the safety and efficacy of its PTL201 capsules in treating spasticity related symptoms of multiple sclerosis patients.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that the Company's Australian distribution partner, Melbourne-based HL Pharma Pty Ltd., has successfully imported its first shipment of medicinal products from the Company's Swiss-subsidiary, Satipharm AG.
Algae.Tec Limited (ASX:AEB) (OTCMKTS:ALGXY) is pleased to announce that it has entered into a Collaboration and Licence Term Sheet with Jardin De Invierno SA to expand its technology and product footprint into the rapidly growing medicinal marijuana and associated markets.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that Harvest One Cannabis Inc. (CVE:HVST) through its wholly-owned subsidiaries United Greeneries Ltd. and United Greeneries Saskatechwan Ltd., has entered into two separate agreements with PanCann Streaming Corp. to finance the construction of both the Lucky Lake facility and a new additional production facility to be identified.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 31 March 2017.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that Harvest One Capital Inc. (CVE:WON.H) has announced the closure of the acquisition of MMJ's wholly-owned subsidiaries United Greeneries Holdings Ltd and Satipharm AG.
MMJ PhytoTech Limited (ASX:MMJ) today confirms that it has closed its previously announced sale of 100% of the issued and outstanding shares of United Greeneries Holdings Ltd. and Satipharm AG from PhytoTechMedical (UK) Pty Ltd., a wholly owned subsidiary of MMJ.
